Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !

Afya Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Afya wird ein jährliches Gewinn- und Umsatzwachstum von 22.9% bzw. 8.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 22.4% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 18.2% betragen.

Wichtige Informationen

22.9%

Wachstumsrate der Gewinne

22.4%

EPS-Wachstumsrate

Consumer Services Gewinnwachstum	27.4%
Wachstumsrate der Einnahmen	8.3%
Zukünftige Eigenkapitalrendite	18.2%
Analystenabdeckung	Good
Zuletzt aktualisiert	04 Jun 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

What Type Of Returns Would Afya's(NASDAQ:AFYA) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Dec 24

Afya BOD approves share buyback program

Dec 23

Afya reports Q3 results

Dec 03

Is Afya Limited's (NASDAQ:AFYA) 10% ROE Strong Compared To Its Industry?

Dec 03

Gewinn- und Umsatzwachstumsprognosen

NasdaqGS:AFYA - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (BRL Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	3,801	877	1,128	1,219	4
12/31/2025	3,479	799	1,032	1,114	7
12/31/2024	3,192	666	872	943	6
3/31/2024	2,970	478	838	1,130	N/A
12/31/2023	2,876	386	798	1,044	N/A
9/30/2023	2,730	355	759	1,024	N/A
6/30/2023	2,587	337	667	953	N/A
3/31/2023	2,473	356	606	897	N/A
12/31/2022	2,329	374	547	844	N/A
9/30/2022	2,243	352	495	818	N/A
6/30/2022	2,117	329	430	738	N/A
3/31/2022	1,891	245	434	730	N/A
12/31/2021	1,719	223	354	631	N/A
9/30/2021	1,566	235	387	591	N/A
6/30/2021	1,421	257	329	503	N/A
3/31/2021	1,323	300	300	449	N/A
12/31/2020	1,201	292	234	372	N/A
9/30/2020	1,077	285	283	377	N/A
6/30/2020	974	257	234	380	N/A
3/31/2020	878	212	210	343	N/A
12/31/2019	751	154	178	299	N/A
9/30/2019	636	128	137	247	N/A
6/30/2019	522	106	119	156	N/A
3/31/2019	417	110	93	120	N/A
12/31/2018	334	86	59	80	N/A
12/31/2017	216	45	N/A	40	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: AFYADas prognostizierte Gewinnwachstum (22.9% pro Jahr) liegt über der Sparquote (2.4%).

Ertrag vs. Markt: AFYADie Erträge des Unternehmens (22.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.7% pro Jahr).

Hohe Wachstumserträge: AFYAEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: AFYADie Einnahmen des Unternehmens (8.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.4% pro Jahr).

Hohe Wachstumseinnahmen: AFYADie Einnahmen des Unternehmens (8.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: AFYADie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (18.2 %).

Afya Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Afya Limited Provides Earnings Guidance for the FY2024

Consensus EPS estimates fall by 14%

Consensus EPS estimates increase by 11%

Consensus EPS estimates increase by 12%

Consensus forecasts updated

Consensus forecasts updated

Recent updates

Afya Limited, Annual General Meeting, Jun 05, 2024

Do Afya's (NASDAQ:AFYA) Earnings Warrant Your Attention?

Afya Limited Reports Unaudited Consolidated Write-Off Results for the First Quarter Ended March 31, 2024

Afya Limited Reports Unaudited Consolidated Write-Off Results for the First Quarter Ended March 31, 2024

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

AFYA: Mr Market Is Mistaken

Is Now The Time To Look At Buying Afya Limited (NASDAQ:AFYA)?

Afya (NASDAQ:AFYA) Seems To Use Debt Quite Sensibly

Afya Is Performing Well And Is A Buy

Full year 2023 earnings: EPS misses analyst expectations

Are Investors Undervaluing Afya Limited (NASDAQ:AFYA) By 39%?

Afya Limited Provides Earnings Guidance for the FY2024

Be Wary Of Afya (NASDAQ:AFYA) And Its Returns On Capital

Afya Limited (NASDAQ:AFYA) Not Lagging Market On Growth Or Pricing

Should You Think About Buying Afya Limited (NASDAQ:AFYA) Now?

Afya Limited to Report Q4, 2023 Results on Mar 14, 2024

These 4 Measures Indicate That Afya (NASDAQ:AFYA) Is Using Debt Reasonably Well

Consensus EPS estimates fall by 14%

Third quarter 2023 earnings: Revenues and EPS in line with analyst expectations

Consensus EPS estimates increase by 11%

Afya (NASDAQ:AFYA) May Have Issues Allocating Its Capital

Afya Limited to Report Q3, 2023 Results on Nov 13, 2023

What Does Afya Limited's (NASDAQ:AFYA) Share Price Indicate?

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Does Afya (NASDAQ:AFYA) Deserve A Spot On Your Watchlist?

Afya Limited to Report Q2, 2023 Results on Aug 28, 2023

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Afya Limited to Report Q1, 2023 Results on May 24, 2023

Afya Limited, Annual General Meeting, Jun 15, 2023

Investor sentiment improves as stock rises 19%

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates increase by 12%

Afya Announces Changes to Its Board of Directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Less than half of directors are independent

Investor sentiment improved over the past week

Afya Limited to Report Q3, 2022 Results on Nov 21, 2022

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Afya GAAP EPS of R$1.12, revenue of R$598.16M; reaffirms FY22 guidance

Investor sentiment improved over the past week

White Brook Capital - AFYA Ltd: Cheap Stock, Good Business, Inherent Growth

Afya Limited to Report Q2, 2022 Results on Aug 22, 2022

Consensus forecasts updated

First quarter 2022 earnings: EPS exceeds analyst expectations

Investor sentiment deteriorated over the past week

Erste Wv GÜTersloh Gmbh signed a basic agreement to acquire additional 2.4% stake in Afya Limited (NasdaqGS:AFYA) from Nicolau Carvalho Esteves Rosângela de Oliveira Tavares Esteves and NRE Capital Ventures Ltd.

Less than half of directors are independent

Afya Limited Announces Changes to its Board of Directors

Afya Limited to Report Q1, 2022 Results on May 23, 2022

Afya Limited, Annual General Meeting, Apr 29, 2022

Afya: Margin And Organic Growth Struggles Remain Top Of Mind

Full year 2021 earnings: EPS misses analyst expectations

Investor sentiment improved over the past week

Consensus forecasts updated

Afya Limited to Report Q4, 2021 Results on Mar 31, 2022

Investor sentiment improved over the past week

Afya On A Grey Price Area

Consensus forecasts updated

Third quarter 2021 earnings: Revenues exceed analyst expectations

Afya: The Longer-Term Growth Story Remains Intact

Afya Limited Provides Earnings Guidance for the Second Half of 2021

Second quarter 2021 earnings released

Director Laura Carvalho has left the company

Bertelsmann SE& Co. KGaA completed the acquisition of 24.7% stake in Afya Limited (NasdaqGS:AFYA) from Bozano Educacional II Fundo de Investimento em Participações manged by Crescera Investimentos.

First quarter 2021 earnings released: EPS R$1.16 (vs R$1.09 in 1Q 2020)

Afya to acquire UNIGRANRIO for R$700M

Afya Limited announced that it has received BRL 822 million in funding from SoftBank Investment Advisers (UK) Limited

Full year 2020 earnings released: EPS R$3.15 (vs R$2.03 in FY 2019)

Afya Limited announced that it expects to receive BRL 822 million in funding from SoftBank Investment Advisers (UK) Limited